Abstract:Background: The pathophysiological processes linked to an acute ischemic stroke (IS) can be reflected in the circulating metabolome. Amino acids (AAs) have been demonstrated to be one of the most significant metabolites that can undergo significant alteration after a stroke. Methods: We sought to identify the potential biomarkers for the early detection of IS using an extensive targeted technique for reliable quantification of 27 different AAs based on ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). A cohort with 216 participants was enrolled, including 70 mild to moderate ischemic stroke patients (National Institutes of Health Stroke Scale < 15, MB group), 76 stroke mimics (MM group) and 70 healthy controls (NC group). Results: It was found that upon comparing MB and MM to control patients, AAs shifts were detected via partial least squares discrimination analysis (PLS-DA) and pathway analysis. Interestingly, MB and MM exhibited similar AAs pattern. Moreover, ornithine, asparagine, valine, citrulline, and cysteine were identified for inclusion in a biomarker panel for early-stage stroke detection based upon an AUC of 0.968 (95% CI 0.924–0.998). Levels of ornithine were positively associated with infract volume, 3 months mRS score, and National Institutes of Health Stroke Scale (NIHSS) score in MB. In addition, a metabolites biomarker panel, including ornithine, taurine, phenylalanine, citrulline, cysteine, yielded an AUC of 0.99 (95% CI 0.966–1) which can be employed to effectively discriminate MM patients from control. Conclusion: Overall, alternations in serum AAs are characteristic metabolic features of MB and MM. AAs could serve as promising biomarkers for the early diagnosis of MB patients since mild to moderate IS patients were enrolled in the study. The metabolism of AAs can be considered as a key indicator for both the prevention and treatment of IS.

Integration of Ultra-High-pressure Liquid Chromatography-Tandem Mass Spectrometry with Machine Learning for Identifying Fatty Acid Metabolite Biomarkers of Ischemic Stroke.

Metabolomic Profiling of Fatty Acid Biomarkers for Intracerebral Hemorrhage Stroke.

Rapid Computer‐Aided Diagnosis of Stroke by Serum Metabolic Fingerprint Based Multi‐Modal Recognition

Identification of Serum Biomarkers of Ischemic Stroke in a Hypertensive Population Based on Metabolomics and Lipidomics

Using machine learning to identify proteomic and metabolomic signatures of stroke in atrial fibrillation

Discovery of Metabolite Biomarkers for Acute Ischemic Stroke Progression

Detection of acute ischemic stroke and backtracking stroke onset time via machine learning analysis of metabolomics

Lipidomic analysis of plasma in patients with lacunar infarction using normal-phase/reversed-phase two-dimensional liquid chromatography–quadrupole time-of-flight mass spectrometry

New strategy for clinical etiologic diagnosis of acute ischemic stroke and blood biomarker discovery based on machine learning

Identification of Blood Biomarkers in Ischemic Stroke by Integrated Analysis of Metabolomics and Proteomics

Thrombosis origin identification of cardioembolism and large artery atherosclerosis by distinct metabolites

A metabonomic approach applied to predict patients with cerebral infarction.

Discovery of a New Biomarker Pattern for Differential Diagnosis of Acute Ischemic Stroke Using Targeted Metabolomics

Potential of serum metabolites for diagnosing post-stroke cognitive impairment.

Metabonomic study of ischemic stroke based on GC-TOFMS approach

Biomarker identification and risk assessment of cardiovascular disease based on untargeted metabolomics and machine learning

Identification of Potential Diagnostic Biomarkers of Cerebral Infarction Using Gas Chromatography-Mass Spectrometry and Chemometrics

Stroke analysis and recognition in functional near-infrared spectroscopy signals using machine learning methods

Targeted metabolomics reveals serum changes of amino acids in mild to moderate ischemic stroke and stroke mimics

Development and Validation of a Machine Learning-Based Model of Ischemic Stroke Risk in the Chinese Elderly Hypertensive Population

Simultaneous determination of trimethylamine N-oxide, choline, betaine by UPLC-MS/MS in human plasma: An application in acute stroke patients.